DOCSLIB.ORG
Sign Up
Log In
Upload
Search
Sign Up
Log In
Upload
Home
» Tags
» Lucanthone
Lucanthone
Restoration of Temozolomide Sensitivity by PARP Inhibitors In
Table of Contents
Induction of Concentration-Dependent Blockade in the G2 Phase of the Cell Cycle by Cancer Chemotherapeutic Agents1
WO 2013/061161 A2 2 May 2013 (02.05.2013) P O P C T
Predicting Potential Drugs for Breast Cancer Based on Mirna and Tissue Specificity
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Quinolizidine-Derived Lucanthone and Amitriptyline Analogues Endowed with Potent Antileishmanial Activity
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Versitat Munster. the Production of Single Strand Breaks
2014 Annual Report
Protocol Update #09 ALLIANCE for CLINICAL TRIALS in ONCOLOGY
Predicting Potential Treatments for Complex Diseases Based on Mirna and Tissue Specificity
Polymerase Inhibitors in Mismatch Repair Deficient Glioblastoma Is Independent of Base Excision
(12) United States Patent (10) Patent No.: US 8,512,679 B2 Hyde Et Al
United States Patent (10) Patent No.: US 9,605,003 B2 Castro Et Al
Studies on the Selectivity of Antitumor Agents1 S
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes